10 Treatments for Menopausal and Post-menopausal Problems Present and Future
Prememenustrual dysphoric disorder and post menopausal syndrome
-
Upload
pavan-kulkarni -
Category
Health & Medicine
-
view
169 -
download
0
Transcript of Prememenustrual dysphoric disorder and post menopausal syndrome
![Page 1: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/1.jpg)
Premenustrual Dysphoric Disorder and Post Menopausal Syndrome
Dr. Pavan Kumar.KAssistant Professor,Dept of Psychiatry
CAIMS
![Page 2: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/2.jpg)
What is Premenstrual Dysphoric Disorder?
• PMDD• Severe PMS (Premenstrual
Syndrome)• Depression, tension and irritability
are common.
![Page 3: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/3.jpg)
Hippocrates (460-377 B.C.)
Described a group of conditions that occurred prior to the onset of menses,
in which women might develop suicidal ideation and other severe symptoms
![Page 4: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/4.jpg)
Frank (in 1931) Described 15 women experiencing severe premenstrual symptoms
and coined the term ‘Premenstrual Tension Syndrome
Green and Dalton (in 1953) coined the term ‘Premenstrual Syndrome’
![Page 5: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/5.jpg)
PMDD is a relatively a new concept!
![Page 6: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/6.jpg)
Our guide!1987DSM-III-R included criteria for Late Luteal Phase Dysphoric Disorder (in Appendix A, proposed diagnostics categories needing further studies)
1994In DSM-IV the name has been changed to Premenstrual Dysphoric DisorderIncluded as a Depressive Disorder Not Otherwise Specified (Appendix B, research criteria)
![Page 7: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/7.jpg)
October 1998,A panel of experts evaluated the evidence then available, and a consensus was reached that PMDD was a distinct clinical entity
A review by a group of experts "reached the consensus that PMDD is a distinct entity with clinical and biological profiles dissimilar to those seen with other disorders"
(Endicott et al. J Womens Health Gend Based Med 1999;8:663-679).
![Page 8: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/8.jpg)
PMDD - a Distinct Clinical Entity?
![Page 9: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/9.jpg)
A distinct clinical presentation with characteristic symptoms
Cyclical course linked to the menstrual cycle
Unique physical symptoms such as bloating and breast tenderness
Cessation of symptoms during pregnancy and after menopause
Rapid response to selective serotonin reuptake inhibitors (SSRIs)—in contrast to
the slower onset in major depressive disorder
Normal hypothalamic-pituitary-adrenal axis functioning—in contrast to major
depression
![Page 10: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/10.jpg)
Causes of PMDD• The Causes are NOT KNOWN.• Hormones play some sort of
role.• Symptoms Disappear if
ovaries are removed.• Ovarian function
may affect changes in brain chemistry.
![Page 11: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/11.jpg)
Incidence of PMDD
• Occurs in in 8% of woman who are having their menstrual cycle.
• May have a genetic disposition. • Daughters of mothers with PMDD are likely to
have the disorder as well.• 93% of Identical twins will
both have PMDD.• 44% of Fraternal twins will
both have PMDD.
![Page 12: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/12.jpg)
Risk Factors
• Anxiety• Major Depression• Seasonal affective disorder• Alcohol abuse• Overweight• Sedentary lifestyle• Family History
![Page 13: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/13.jpg)
In most menstrual cycles during the past year, five (or more) of the following symptoms were present
for most of the time during the last week of the luteal phase,
began to remit within a few days after the onset of the follicular phase,
and were absent in the week post-menses, with at least one of the symptoms being either (1), (2), (3), or (4).
![Page 14: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/14.jpg)
markedly depressed mood, feelings of hopelessness, or self-deprecating thoughts
![Page 15: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/15.jpg)
marked anxiety, tension, feelings of being "keyed up," or "on edge"
![Page 16: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/16.jpg)
marked affective lability (e.g., feeling suddenly sad or tearful or increased sensitivity to rejection)
![Page 17: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/17.jpg)
persistent and marked anger or irritability or increased interpersonal conflicts
![Page 18: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/18.jpg)
(e.g. work, school, friends, hobbies)
![Page 19: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/19.jpg)
Symptoms absent, the week after the onset of menses (Follicular
Phase)
Symptoms subside few days after the onset of menses
Symptoms present in the last week of Luteal Phase
![Page 20: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/20.jpg)
In the most menstrual cycles during the past one year
![Page 21: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/21.jpg)
The disturbance markedly interferes with work or school or with usual social activities and relationships with others (e.g., avoidance of social activities, decreased productivity and efficiency at work or school).
![Page 22: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/22.jpg)
The disturbance is not merely an exacerbation of the symptoms of another disorder, such as Major Depressive Disorder, Panic Disorder, Dysthymic Disorder, or a Personality Disorder (although it may be superimposed on any of these disorders).
![Page 23: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/23.jpg)
How to diagnose PMDD ?
• No physical exam or lab test can diagnose PMDD.• Psychiatric evaluation is used to rule out other
conditions.• Keep a calendar or diary of symptoms when they
occurred to help with a diagnosis and best course of treatment.
![Page 24: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/24.jpg)
Diagnostic InstrumentsDRSP Daily Record of Severity of Problems
PSST Premenstrual Symptoms Screening Tool
COPE Calendar of Premenstrual Experiences
VAS Visual Analogue Scale
DSR Penn Daily Symptom Report Scale
The reliability and validity of the DRSP were confirmed recently in two studies reported by Endicott et al. (Arch Womens Ment Health 2006;9:41-49).
![Page 25: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/25.jpg)
![Page 26: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/26.jpg)
Symptoms
AnxietyDepressionIrritabilityLability of moodConcentration difficultySleep disturbanceFood cravings, overeatingAnhedonia
Breast tendernessBloatingBreast engorgementHeadachesMuscle or joint painWeight gain
![Page 27: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/27.jpg)
![Page 28: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/28.jpg)
ICD - 10
Requires only one physical or emotional symptom to make the diagnosis of PMS
ICD-10 does not include PMDD as a diagnosis
![Page 29: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/29.jpg)
Differential Diagnosis
Premenstrual Syndrome
Premenstrual exacerbation of current mental disorder
Premenstrual exacerbation of general medical condition such as epilepsy, asthma or endocrine disorders
![Page 30: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/30.jpg)
![Page 31: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/31.jpg)
![Page 32: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/32.jpg)
What goes wrong?
Common sense assumption
Assumption 1There might be a different hormone status in females with PMDD than those who do not have these symptoms
![Page 33: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/33.jpg)
What goes wrong?
Common sense assumption
Assumption 2There might be serotonin depletion in PMDD, mainly in the luteal phase of menstruation!??
![Page 34: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/34.jpg)
What data has to say?
premenstrual syndrome is probably the result of a complex interaction between ovarian steroids and central neurotransmitters(N Engl J Med 1998;338:256-257)
![Page 35: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/35.jpg)
Regular hormones levels
No consistent difference in blood and urine level of estrogen and progesterone in women with PMDD compared to those without disorder.
![Page 36: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/36.jpg)
Why hormones involved?
If the fluctuation of hormones is somehow stopped,
the premenstrual symptoms improve!
![Page 37: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/37.jpg)
GnRH agonists improves PMSSchmidt and colleagues used leuprolide, a GnRH agonist, to block endogenous production of estrogen and progesterone in 10 women with PMS
conclusion: There was a significant decrease in PMS symptoms compared to
baseline and compared to a placebo group. This was followed by a marked worsening of PMS symptoms when
estrogen or progesterone was added to leuprolide in the women who had benefited previously. (N Engl J Med 1998;338:209-216)
![Page 38: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/38.jpg)
GnRH agonists improves PMS
Other supporting studiesFreeman EW, Sondheitjer SH, Rickets K. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without ongoing dysphorics: a controlled study. Psychopharmacol Bull. 1997;33:303-309
Hammarback S, Backstrom T.Induced anovulation as treatment of premenstrual tension syndrome: a double-blind cross-over study with GnRH-agonist versus placebo. Acta Obstet Gynecol Scand. 1988;67:159-166.
![Page 39: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/39.jpg)
Progesterone alone Used for many yearsNo supporting evidence
Progesterone has not been demonstrated to work better than placebo for treatment of mood symptoms of PMS.
-Ford O, Lethaby A, Mol B, Roberts H. Progesterone for premenstrual syndrome. Cochrane Database Syst Rev. 2006;(4):CD003415.
-Wyatt K, Dimmock P, Jones P, Obhrai M, O'Brien E. Efficacy of progesterone and progestins in management of premenstrual symptoms: a systematic review. BMJ. 2001;323:776-780
![Page 40: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/40.jpg)
OC pills to suppress ovulation
![Page 41: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/41.jpg)
Neurotransmitters
Retrospective evidence of Serotonin involvement- as the symptoms improves with SSRIs
SerotoninIncrease allopregnanolone synthesis
Increase sensitivity to neurosteroids
SSRIsThe effect is unrelated to the serotonin uptake inhibiting property of these drugs
![Page 42: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/42.jpg)
Genetic susceptibility
A preliminary study suggested that genetic variation in the estrogen receptor alpha gene is associated with increased risk for PMDD;
leading the authors to speculate that there might be a "genetic susceptibility to affective dysregulation induced by normal levels of gonadal steroids" (Huo et al. Biol Psychiatry 2007;62:925-933).
![Page 43: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/43.jpg)
How can we go about helping her?
![Page 44: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/44.jpg)
![Page 45: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/45.jpg)
UpdateA brief update on diagnosis and treatment, "Expert Guidelines for the Treatment of Severe PMS, PMDD, and Comorbidities: The Role of SSRIs“published in 2006 by Steiner et al. (J Womens Health (Larchmt) 2006;15:57-69).
![Page 46: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/46.jpg)
Recent review
A more recent overview on treatment of PMDD is provided by Yonkers and colleagues (Lancet 2008;371:1200-1210).
The pharmacologic treatment of PMDD was reviewed recently by Rapkin and Winer (Expert Opin Pharmacother 2008;9:429-445) and Steiner et al. (J Womens Health 2006;15:57-69).
![Page 47: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/47.jpg)
![Page 48: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/48.jpg)
CBT Comparision with Fluoxetine and combination of Fluoxetine
and CBT
all three equally effective; though the response with Fluoxetine faster
more sustained benefit from CBT after termination of treatment
(Hunter et al. J Psychosom Obstet Gynecol 2002;23:193-199).
![Page 49: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/49.jpg)
Nutritional approaches
Dietary modifications are recommended widely to relieve symptoms of PMS, but whether they are effective for treating the more severe symptoms of PMDD has not been established
Again more studies for PMS; so ?? For severe symptoms of PMDD.Limitations:Poor study design, Vague definition of PMS, High placebo response(review by Bendich. J Am Coll Nutr 2000;19:3-12)
![Page 50: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/50.jpg)
General nutritional recommendationLimit intake of alcohol, caffeine, salt, tobacco, and refined sugars
Increase complex carbohydrate and protein intake
Avoid overeating and weight gain
Consider frequent small meals
![Page 51: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/51.jpg)
Pyridoxine (vitamin B6)
Despite the limitation of study designs.100 mg/day benefits in premenstrual symptoms
by Wyatt et al. (BMJ 1999;318:1375-1381)
![Page 52: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/52.jpg)
Medication Treatment
SSRIsOther antidepressants
HormonesAnxiolyticsAnalgesicsDiureticsClonidineLithium
![Page 53: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/53.jpg)
SSRIs
A thorough review of SSRIs by Dimmock and colleagues
Evaluated 15 high quality randomized placebo-controlled trials
(Lancet 2000;356:1131-1136)
![Page 54: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/54.jpg)
SSRIsOverall, the SSRIs were 6.9 times more effective than placebo.
With the exception of one negative study with fluvoxamine, results with SSRIs for PMDD have been uniformly positive
Drugs evaluated: Fluoxetine, Sertraline
Full cycle-more, few intermittent- same benefit
Unable to determine dose-response relationship (Lancet 2000;356:1131-1136)
![Page 55: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/55.jpg)
Very severe symptoms
Danazole
GnRH agonists
Surgical removal of ovaries
![Page 56: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/56.jpg)
Treatment of PMDD
• A healthy lifestyle is the first step to managing PMDD.
• Eat a Balanced Diet• Get sufficient sleep• Exercise• Keep a track of your symptoms
• Other Treatments:» Birth control Pills» Diuretics» Nutritional supplements» Antidepressants» CBT (Congenital behavioral Therapy)
![Page 57: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/57.jpg)
POST MENOPAUSAL SYNDROME
![Page 58: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/58.jpg)
• The average age of menopause in India is 47.5years with an average life expectancy of 71years.
• So.., Indian women are likely to spend 23 years in menopause.– Indian menopause Society, 2007
![Page 59: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/59.jpg)
• Prakash and Murthy etal..– A study done in 1981, observed the relationship
between menopause and psychiatric morbidity by using GHQ, Psychiatric interview found highest psychiatric morbidity in the menopausal group.
![Page 60: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/60.jpg)
• Menopause is the permanent cessation of menstruation resulting in the loss of ovarian follicle development.
• Factors that are toxic to the ovary often result in an earlier age of menopause.
• Premature ovarian failure is defined as menopause before the age of 40 years
![Page 61: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/61.jpg)
• Although menopause is associated with changes in the hypothalamic and pituitary hormones that regulate the menstrual cycle, menopause is not a central event, but rather a primary ovarian failure.
![Page 62: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/62.jpg)
![Page 63: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/63.jpg)
• Menopausal transition or perimenopause is a defined period of time beginning with the onset of irregular menstrual cycles until the last menstrual period and is marked by fluctuation in reproductive harmones.
• This period is characterised by menustrual irregularities, prolonged and heavy menustruation intermixed with episodes of amenorrhea, decreased fertility, vasomotor symptoms and insomnia.
![Page 64: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/64.jpg)
• Menopause is defined retrospectively as the time of the final menustrual period , followed by 12months of amenorrhea.
• Post menopause describes the period following the final menses.
![Page 65: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/65.jpg)
![Page 66: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/66.jpg)
• Vasomotor symptoms• Urogenital symptoms• Osteoporosis• Psychological problems
![Page 67: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/67.jpg)
VASOMOTOR SYMPTOMS
• Affects upto 75% of perimenopausal women.• May last usually upto 1-2yrs but in some upto
10years.• Hot Flushes • Fatigue• Should be differentiated from thyroid
abnormalities.
![Page 68: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/68.jpg)
• Probably initiated in hypothalamus, which drives an increased core body temperature, metabolic rate and skin temperature, resulting in peripheral vasodilatation and sweating.
• This may be triggered by 5HT, NE, DA activation.
![Page 69: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/69.jpg)
• These symptoms are managed by • Estrogen • Progesterone MPA (20mg/day)• Clonidine• SSRIS
![Page 70: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/70.jpg)
ACOG updated Practice Bulletin- treating vasomotor symptoms and vaginal atrophy-JAN
2014
• more evidence to support nonhormonal alternatives (SSRI & SNRI) for management of vasomotor symptoms.(paroxetine-only FDA approved)
• transdermal delivery is safer than oral.(ACOG2013)
![Page 71: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/71.jpg)
Urogenital atrophy
• Vaginal dryness, pruritis, dyspareunia, dysuria and urgency.
• Treatment: • These symptoms respond to estrogen therapy.
May be given orally/local application of creams / vaginal suppository.
![Page 72: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/72.jpg)
Osteoporosis
• Backache, fractures, decreased mobility are common due to osteoporosis.
• Women should recieve 1000-1500 mg calcium supplementation
• 400-800 IU of Vit D daily.• HRT is effective in preventing and treating
osteoporosis.• SERM : RAL0XIFEN 60MG• BISPHOSPHONATES
![Page 73: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/73.jpg)
Psychological symptoms
• Depression • Cognitve problems• Sleep problems
![Page 74: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/74.jpg)
Depression
• Because of fluctuating and declining estrogen levels in part.
• Steroid hormones like estrogens act by stimulating the synthesis of neurotransmitters, expression of receptors and influence membrane permeability.
• Estrogen increases the effect of serotonin and nor epinephrine which mediate mood.
![Page 75: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/75.jpg)
• Alternate mechanism is estrogen decreases MAO.
• Although precise mechanisms are not known, fluctuations in estrogen levels affect the regulation of serotonin and norepinephrine.
• LIFE STRESSORS• EMPTY NEST SYNDROME• LOSS OF FERTILITY
![Page 76: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/76.jpg)
Treatment
• SSRI• ESTROGEN • MPA
![Page 77: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/77.jpg)
COGNITIVE FUNCTIONS
• Memory problems are common in menopausal transition rather than aging process.
• Cognitive difficulties may be a consequence of sleep disruptions secondary to nocturnal hot flushes.
• Women are at greater risk for Alzheimer’s disease than men.
![Page 78: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/78.jpg)
Sleep disorders
• Insomnia occurs in 40-50% women during the menopausal transition.
• Age related???• Decrease in melatonin may be one of the
reason.
![Page 79: Prememenustrual dysphoric disorder and post menopausal syndrome](https://reader036.fdocuments.us/reader036/viewer/2022081521/58ac6b731a28abd7488b5d17/html5/thumbnails/79.jpg)
Cp5